Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Breast Cancer in Hispanic Women

Correlating SNPs with risk

The correlation between genetic ancestry, hormone replacement therapy use, and breast feeding behavior partially explain an interaction between a breast cancer risk variant and genetic ancestry in Hispanic women. This according to a study of 10 single nucleotide polymorphisms (SNPs) identified through genome-wide association studies in 2,107 Hispanic women with breast cancer and 2,587 unaffected controls. Researchers found that SNP Rs13387042-2q35(G/A) was associated with breast cancer risk only among:

• Postmenopausal women who never used hormone therapy. Odds ratios were 0.94, 1.20, and 1.49 for current hormone therapy users, previous users, and never users, respectively.

• Premenopausal women who breastfed > 12 months. Odds ratios were 1.01, 1.19, and 1.69 for women who never breastfed, breastfed < 12 months, and > 12 months, respectively.

Citation: Fejerman L, Stern MC, John EM, et al. Interaction between common breast cancer susceptibility variants, genetic ancestry, and non-genetic risk factors in Hispanic women. [Published online ahead of print September 12, 2015]. Cancer Epidemiol Biomarkers Prev. doi: 10.1158/1055-9965.EPI-15-0392.